Although oral corticosteroids
have been used for many years in the non-athletic population, there are few published reports on the magnitude of risk of health-related complications and the determinants of this risk in the athletic population.
are used for a wide variety of conditions with the therapeutic goal of reducing inflammation.
1] There is an obvious dose-duration-response relationship between corticosteroids
and ONFH, although it is disputable.
Our study finds that antenatal (before birth) corticosteroids
given to pregnant women only hours before delivery were associated with a survival advantage for their infants", says Mikael Norman, lead author, neonatologist and professor at Karolinska Institutet's Department of Clinical Science, Intervention and Technology in Stockholm, Sweden.
have been demonstrated to cause local vasoconstriction and skin blanching followed by rebound vasodilation, and the observed skin changes can be evidence of corticosteroid
In group A, patients were given oral corticosteroids
after the surgery (for one month duration, deltacortil 1mg/kg body weight for two weeks and tapering off in the next two weeks followed by local corticosteroid
) and Group B individuals were put on topical corticosteroids
soon after the surgery.
In women at risk of preterm delivery, antenatal corticosteroids
given between 1 and 7 days before birth reduce infant mortality by an estimated 31%, respiratory distress syndrome by 34%, intraventricular hemorrhage by 46%, and necrotizing enterocolitis by 54%.
reduce preterm newborn morbidity and mortality.
plus high-potency topical corticosteroids
may reduce the duration of the itching.
Skin conditions that are characterized by hyperproliferation, inflammation, and immunologic involvement can be effectively treated by topical corticosteroids
KEY WORDS: Idiopathic Pulmonary Haemosiderosis, Corticosteroids
The efficacy results suggest that pimecrolimus has similar efficacy to topical corticosteroids
in a real-world setting, which is noteworthy because pimecrolimus is not currently widely used as first-line therapy for atopic dermatitis, given the perception of lower efficacy than topical corticosteroids